Ocular’s Dry Eye Drug Fails In Phase II, But It Isn’t Giving Up Yet

 
• By Joseph Haas
  
Blood shot eyes
Ocular Therapeutics is working on two intracanicular inserts for dry eye disease
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D